Claims
- 1. A composition comprising a compound according to formula (II),
- 2. The composition of claim 1, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 3. The composition of claim 1, wherein the compound is in a form of a salt or a prodrug.
- 4. The composition of claim 3, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 5. A composition comprising a compound according to formula (III),
- 6. The composition of claim 5, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 7. The composition of claim 5, wherein the compound is in a form of a salt or a prodrug.
- 8. The composition of claim 7, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 9. The composition of claim 5, wherein R is a heterocyclic group.
- 10. The composition of claim 9, wherein the heterocyclic group is
- 11. The composition of claim 10, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 12. The composition of claim 10, wherein n is 0.
- 13. The composition of claim 12, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 14. The composition of claim 12, wherein the compound is in a form of a salt or a prodrug.
- 15. The composition of claim 14, further comprising at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
- 16. A method for treating a cancerous condition, comprising:
selecting a composition comprising an ingredient selected from the group consisting of a compound of formula (II), a compound of formula (III), a pharmaceutically acceptable salt of formula (II), a pharmaceutically acceptable prodrug of formula (II), a pharmaceutically acceptable salt of formula (III), and a pharmaceutically acceptable prodrug of formula (III); and administering a treatment effective amount of the composition to a subject.
- 17. The method of claim 16, wherein the administering comprises one selected from the group consisting of oral administration, injection, and administering a suppository.
- 18. The method of claim 16, wherein the subject is a mammal.
- 19. A method for manufacturing a pharmaceutical composition, comprising:
selecting an ingredient selected from the group consisting of a compound of formula (II), a compound of formula (III), a pharmaceutically acceptable salt of formula (II), a pharmaceutically acceptable prodrug of formula (II), a pharmaceutically acceptable salt of formula (III), and a pharmaceutically acceptable prodrug of formula (III); and preparing the pharmaceutical composition using the ingredient and at least one selected from the group consisting of a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, and a pharmaceutically acceptable excipient.
RELATED APPLICATION
[0001] The invention claims priority from Provisional Application Serial No. 60/281,531, filed on Apr. 3, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60281531 |
Apr 2001 |
US |